Search

Your search keyword '"Cobb, Kaitlan"' showing total 19 results
Start Over Author "Cobb, Kaitlan"
19 results on '"Cobb, Kaitlan"'

3. Long-Term Antibiotic Treatment Prior to Laparoscopic Nephrectomy for Xanthogranulomatous Pyelonephritis Improves Postoperative Outcomes: Results from a Multicenter Study

Author

Xie, Lillian, primary, Tapiero, Shlomi, additional, Flores, Alec R., additional, Armas-Phan, Manuel, additional, Limfueco, Luke, additional, Karani, Rajiv, additional, Jiang, Pengbo, additional, Cobb, Kaitlan D., additional, Sur, Roger L., additional, Chi, Thomas, additional, Landman, Jaime, additional, Kaler, Kamaljot S., additional, and Clayman, Ralph V., additional

Published
2021
Full Text
View/download PDF

6. MP77-20 THE IMPACT OF LONG-TERM ANTIBIOTICS PRIOR TO NEPHRECTOMY FOR XANTHOGRANULOMATOUS PYELONEPHRITIS: MULTICENTER EVALUATION OF OPERATIVE OUTCOMES

Author

Xie*, Lillian, primary, Tapiero, Shlomi, additional, Flores, Alec R., additional, Armas-Phan, Manuel, additional, Jiang, Pengbo, additional, Kaler, Kamaljot S., additional, Karani, Rajiv, additional, Cobb, Kaitlan D., additional, Sur, Roger L., additional, Chi, Thomas, additional, Landman, Jaime, additional, and Clayman, Ralph V., additional

Published
2020
Full Text
View/download PDF

7. MP15-06 INDICATIONS FOR STENT OMISSION AFTER URETEROSCOPIC LITHOTRIPSY: A PROSPECTIVE TRIAL FROM THE REGISTRY FOR STONES OF THE KIDNEY AND URETER (RESKU)

Author

Fisher*, Robert, primary, Cobb, Kaitlan, additional, Friedlander, David, additional, Bayne, David, additional, Bechis, Seth, additional, Chang, Helena, additional, Chi, Thomas, additional, Duty, Brian, additional, Harper, Jonathan, additional, Metzler, Ian, additional, Sorensen, Mathew, additional, Stoller, Marshall, additional, Tzou, David, additional, and Sur, Roger, additional

Published
2020
Full Text
View/download PDF

12. Antibiotics are not necessary during routine cystoscopic stent removal: A randomized controlled trial at UC San Diego.

Author

Bradshaw, Aaron, Pe, Mark, Bechis, Seth, Dipina, Thomas, Zupkas, Paul, Abbott, Joel, Papagiannopoulos, Dimitri, Cobb, Kaitlan, and Sur, Roger

Subjects
ANTIBIOTIC prophylaxis, CYSTOSCOPY, RANDOMIZED controlled trials, INSTITUTIONAL review boards, SURGICAL stents, URINARY tract infections, ANTIBIOTICS
Abstract

Introduction: Current American Urological Association (AUA) Best Practice Statement recommends antibiotic prophylaxis for cystoscopy with manipulation, including stent removal; although no Level 1b trials explicitly address prophylaxis for stent removal. We sought to determine the efficacy of prophylactic antibiotics to prevent infectious complications after stent removal. Materials and Methods: Following institutional review board approval, patients undergoing removal of ureteral stent placed during stone surgery were recruited from July 2016 to March 2019. Patients were recruited at the time of stent removal and randomized to treatment (single dose 500 mg oral ciprofloxacin) or control group (no antibiotics). Telephone contact was attempted within 14 days of stent removal to assess for urinary tract infection (UTI) symptoms, antibiotic prescriptions, or Emergency Department visits. Primary outcome was UTI within 1 month of stent removal – defined by irritative voiding symptoms, fever or abdominal pain associated with positive urine culture (Ucx) (>100k colony-forming units/mL). Results: Seventy-seven patients were enrolled, with 58 meeting final inclusion criteria for the analysis (33 treatment, 25 controls). No differences were seen with clinical and demographic variables, except a higher body mass index in the treatment group (P = 0.007). Positive Ucx rate before stone surgery (16.7% vs. 11.8%, P = 0.819) and at the time of stent removal (16.0% vs. 11.1%, P = 0.648) was not significantly different in treatment versus control groups, respectively. Primary outcome: No patients in either cohort developed symptomatic culture-diagnosed UTI within 1 month of stent removal. Of patients with documented phone follow-up (treatment n = 29, control n = 22), only one patient (control) reported any positive response on phone survey. Conclusions: We found a low infectious complication rate regardless of antibiotic prophylaxis use during cystoscopic stent removal. The necessity of antibiotics during routine cystoscopic stent removal warrants possible reevaluation of the AUA best practice statement. [ABSTRACT FROM AUTHOR]

Published
2020
Full Text
View/download PDF

13. V12-07 IMPLEMENTATION OF MULTIPARAMETRIC MAGNETIC RESONANCE IMAGING INTO ROBOTIC – ASSISTED RADICAL PROSTATECTOMY USING VIRTUAL REALITY

Author

Mehralivand, Sherif, primary, Kolagunda, Abhishek, additional, Kambhamettu, Chandra, additional, Hammerich, Kai, additional, Cobb, Kaitlan, additional, Valera Romero, Vladimir, additional, Bloom, Jonathan, additional, Pena Lagrave, Gustavo, additional, Sabarwal, Vikram, additional, Gold, Samuel, additional, Hale, Graham, additional, Rayn, Kareem, additional, Harmon, Stephanie, additional, Smith, Clayton, additional, Czarniecki, Marcin, additional, Wood, Bradford, additional, Choyke, Peter, additional, Turkbey, Baris, additional, and Pinto, Peter, additional

Published
2018
Full Text
View/download PDF

15. PD40-09 A MULTIPARAMETRIC MAGNETIC RESONANCE IMAGING – BASED VIRTUAL REALITY SURGICAL AID FOR ROBOTIC – ASSISTED RADICAL PROSTATECTOMY

Author

Mehralivand, Sherif, primary, Kolagunda, Abhishek, additional, Kambhamettu, Chandra, additional, Hammerich, Kai, additional, Cobb, Kaitlan, additional, Valera Romero, Vladimir, additional, Bloom, Jonathan, additional, Pena Lagrave, Gustavo, additional, Sabarwal, Vikram, additional, Gold, Samuel, additional, Hale, Graham, additional, Rayn, Kareem, additional, Czarniecki, Marcin, additional, Wood, Bradford, additional, Choyke, Peter, additional, Turkbey, Baris, additional, and Pinto, Peter, additional

Published
2018
Full Text
View/download PDF

19. MRI-targeted biopsy: is systematic biopsy obsolete?

Author

Sugano D, Sidana A, Calio B, Cobb K, Turkbey B, and Pinto PA

Subjects
Humans, Male, Randomized Controlled Trials as Topic, Image-Guided Biopsy statistics & numerical data, Magnetic Resonance Imaging, Prostate pathology, Prostatic Neoplasms pathology
Abstract

Introduction: Although prostate cancer is the most common non-cutaneous cancer in men, it is traditionally diagnosed with a non-targeted, systematic transrectal ultrasound prostate biopsy (TRUS-Bx). This technique has been demonstrated to both under-detect clinically significant (CS) cancer and over-detect clinically insignificant cancer, and performs poorly in patients with a prior negative biopsy. With recent advances in MRI technology, most prominently the advent of multiparametric MRI, MRI-targeted prostate biopsy (MRI-TB) has been gaining favor as a more accurate alternative to TRUS-Bx. In this review, we attempt to summarize the current literature on MRI-TB and to determine if there is evidence supporting the use of MRI-TB alone., Materials and Methods: The literature was reviewed for articles pertaining to MRI-TB and its performance compared to systematic biopsy., Results: Most studies support the increased sensitivity of MRI-TB (0.90, 95% CI 0.85-0.94) compared to TRUS-Bx (0.79, 95% CI 0.68-0.87) for the detection of CS prostate cancer, as MRI-TB can detect up to 30% more high risk and 17% fewer low risk cancers. MRI-TB also tends to perform better than TRUS-Bx in patients with prior negative biopsy, as TRUS-Bx may miss up to half of CS cancers detected by MRI-TB, and in those with lesions at atypical locations. However, as the technology for imaging and image-guided biopsies continues to develop, there is still a role for TRUS-Bx in the management of patients with prostate cancer., Conclusions: Our analysis of the literature suggests that although MRI-TB is superior to TRUS-Bx, there is still a role for traditional systematic biopsy.

Published
2017

Catalog

Books, media, physical & digital resources
See catalog results